Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dechra Pharmaceutical
Pharma
Dechra continues growth spurt with $41M acquisition of Apex
The U.K.’s Dechra Pharmaceuticals has been on an acquisition binge over the last year. Now it’s expanding its geographic footprint even further, picking up Australia’s Apex Laboratories for AU$55 million ($41.2 million).
Arlene Weintraub
Sep 16, 2016 2:33pm
Dechra charts strong growth with new drug approvals and global expansion
Feb 22, 2016 8:37am